2m 2m 2m 2m 2m 2m 2m
TEVA PHARMA IND (TEVA)
NYSE
$39.96+$0.55 (+1.38%)
Price as of Oct 26, 2026 5:21 PM EDT- $47.9BMarket Cap
- 107.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVA PHARMA IND (TEVA)
$39.96+$0.55 (+1.38%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.41 | ||
Change | -$0.80 (-1.99%) | ||
Open | $39.75 | ||
High | $39.84 | ||
Low | $39.10 | ||
Previous Close | $40.21 | ||
Volume | 5,598,870 | ||
30-Day Average Volume | 6,157,291 | ||
1-Week Change | -5.04% | ||
1-Month Change | 1.03% | ||
1-Year Change | 107.97% | ||
3-Year Change | 381.78% | ||
5-Year Change | 289.04% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $39.9B | ||
Market Cap | $47.9B | ||
Enterprise Value | $60.9B | ||
Period: QTR TTM FY | |||
Revenue | $4.1B | ||
Net Income | -$576.0M | ||
Free Cash Flow | $306.0M | ||
EBIT | -$455.0M | ||
EBITDA | -$214.0M | ||
Net Working Capital | -$1.9B | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -284 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 6 | ||
P/E | -80 | ||
PEG | 0 | ||
Price/Free Cash Flow | 157 | ||
Price/Operating Cash Flow | 117 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 07/01/2004 | ||
Earnings & Revenue